India could reduce the 10-year transition period for introducing process patents on pharmaceuticals if "there is a balance of advantage in doing so," Commerce Minister Pranab Mukherjee disclosed in New Delhi. He told a meeting of the World Economic Forum meeting there that an "expert group is looking at all the possible angles." The Commerce Minister's statement is being interpreted as a departure from the stand held all along by an expert group on the subject. Mr Mukherjee said a bill on the exclusive marketing rights of the pharmaceutical sector would be introduced during the winter session of Parliment, which began December 7.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze